224 related articles for article (PubMed ID: 26692333)
1. Loss of the proteostasis factor AIRAPL causes myeloid transformation by deregulating IGF-1 signaling.
Osorio FG; Soria-Valles C; Santiago-Fernández O; Bernal T; Mittelbrunn M; Colado E; Rodríguez F; Bonzon-Kulichenko E; Vázquez J; Porta-de-la-Riva M; Cerón J; Fueyo A; Li J; Green AR; Freije JM; López-Otín C
Nat Med; 2016 Jan; 22(1):91-6. PubMed ID: 26692333
[TBL] [Abstract][Full Text] [Related]
2. Proteostasis alterations in myeloproliferative neoplasms: Oncogenic relevance and therapeutic opportunities.
Santiago-Fernández O; Osorio FG; López-Otín C
Exp Hematol; 2016 Jul; 44(7):574-7. PubMed ID: 27090962
[TBL] [Abstract][Full Text] [Related]
3. The novel tumor suppressor AIRAPL regulates IGF1R proteostasis.
Osorio FG; Freije JM; López-Otín C
Cell Cycle; 2016; 15(7):873-4. PubMed ID: 26901531
[No Abstract] [Full Text] [Related]
4. Signal-peptide-mediated translocation is regulated by a p97-AIRAPL complex.
Glinka T; Alter J; Braunstein I; Tzach L; Wei Sheng C; Geifman S; Edelmann MJ; Kessler BM; Stanhill A
Biochem J; 2014 Jan; 457(2):253-61. PubMed ID: 24160817
[TBL] [Abstract][Full Text] [Related]
5. Targeting a regulator of protein homeostasis in myeloproliferative neoplasms.
LaFave LM; Levine RL
Nat Med; 2016 Jan; 22(1):20-1. PubMed ID: 26735404
[No Abstract] [Full Text] [Related]
6. Expression level and differential JAK2-V617F-binding of the adaptor protein Lnk regulates JAK2-mediated signals in myeloproliferative neoplasms.
Baran-Marszak F; Magdoud H; Desterke C; Alvarado A; Roger C; Harel S; Mazoyer E; Cassinat B; Chevret S; Tonetti C; Giraudier S; Fenaux P; Cymbalista F; Varin-Blank N; Le Bousse-Kerdilès MC; Kiladjian JJ; Velazquez L
Blood; 2010 Dec; 116(26):5961-71. PubMed ID: 20870899
[TBL] [Abstract][Full Text] [Related]
7. Insulin and IGF-1 receptors regulate FoxO-mediated signaling in muscle proteostasis.
O'Neill BT; Lee KY; Klaus K; Softic S; Krumpoch MT; Fentz J; Stanford KI; Robinson MM; Cai W; Kleinridders A; Pereira RO; Hirshman MF; Abel ED; Accili D; Goodyear LJ; Nair KS; Kahn CR
J Clin Invest; 2016 Sep; 126(9):3433-46. PubMed ID: 27525440
[TBL] [Abstract][Full Text] [Related]
8. Insulin/IGF-1-mediated longevity is marked by reduced protein metabolism.
Stout GJ; Stigter EC; Essers PB; Mulder KW; Kolkman A; Snijders DS; van den Broek NJ; Betist MC; Korswagen HC; Macinnes AW; Brenkman AB
Mol Syst Biol; 2013 Jul; 9():679. PubMed ID: 23820781
[TBL] [Abstract][Full Text] [Related]
9. IGFBP7 binds to the IGF-1 receptor and blocks its activation by insulin-like growth factors.
Evdokimova V; Tognon CE; Benatar T; Yang W; Krutikov K; Pollak M; Sorensen PH; Seth A
Sci Signal; 2012 Dec; 5(255):ra92. PubMed ID: 23250396
[TBL] [Abstract][Full Text] [Related]
10. End-of-life targeted degradation of DAF-2 insulin/IGF-1 receptor promotes longevity free from growth-related pathologies.
Venz R; Pekec T; Katic I; Ciosk R; Ewald CY
Elife; 2021 Sep; 10():. PubMed ID: 34505574
[TBL] [Abstract][Full Text] [Related]
11. Insulin/IGF-1 signaling regulates proteasome activity through the deubiquitinating enzyme UBH-4.
Matilainen O; Arpalahti L; Rantanen V; Hautaniemi S; Holmberg CI
Cell Rep; 2013 Jun; 3(6):1980-95. PubMed ID: 23770237
[TBL] [Abstract][Full Text] [Related]
12. SHC-1/p52Shc targets the insulin/IGF-1 and JNK signaling pathways to modulate life span and stress response in C. elegans.
Neumann-Haefelin E; Qi W; Finkbeiner E; Walz G; Baumeister R; Hertweck M
Genes Dev; 2008 Oct; 22(19):2721-35. PubMed ID: 18832074
[TBL] [Abstract][Full Text] [Related]
13. Cytoplasmic LSM-1 protein regulates stress responses through the insulin/IGF-1 signaling pathway in Caenorhabditis elegans.
Cornes E; Porta-De-La-Riva M; Aristizábal-Corrales D; Brokate-Llanos AM; García-Rodríguez FJ; Ertl I; Díaz M; Fontrodona L; Reis K; Johnsen R; Baillie D; Muñoz MJ; Sarov M; Dupuy D; Cerón J
RNA; 2015 Sep; 21(9):1544-53. PubMed ID: 26150554
[TBL] [Abstract][Full Text] [Related]
14. The Zinc-Finger AN1-Type Domain 2a Gene Acts as a Regulator of Cell Survival in Human Melanoma: Role of E3-Ligase cIAP2.
Pizzato Scomazzon S; Riccio A; Santopolo S; Lanzilli G; Coccia M; Rossi A; Santoro MG
Mol Cancer Res; 2019 Dec; 17(12):2444-2456. PubMed ID: 31540997
[TBL] [Abstract][Full Text] [Related]
15. The inhibition of IGF-1 signaling promotes proteostasis by enhancing protein aggregation and deposition.
Moll L; Ben-Gedalya T; Reuveni H; Cohen E
FASEB J; 2016 Apr; 30(4):1656-69. PubMed ID: 26722006
[TBL] [Abstract][Full Text] [Related]
16. The Grb10/Nedd4 complex regulates ligand-induced ubiquitination and stability of the insulin-like growth factor I receptor.
Vecchione A; Marchese A; Henry P; Rotin D; Morrione A
Mol Cell Biol; 2003 May; 23(9):3363-72. PubMed ID: 12697834
[TBL] [Abstract][Full Text] [Related]
17. Differential cytotoxic activity of pharmacological inhibitors of IGF1R-related pathways in JAK2
Fernandes JC; Fenerich BA; Alves-Silva AB; Fonseca NP; Coelho-Silva JL; Scheucher PS; Rego EM; Figueiredo-Pontes LL; Machado-Neto JA; Traina F
Toxicol In Vitro; 2022 Sep; 83():105384. PubMed ID: 35568132
[TBL] [Abstract][Full Text] [Related]
18. IGF signaling contributes to malignant transformation of hematopoietic progenitors by the MLL-AF9 oncoprotein.
Jenkins CE; Shevchuk OO; Giambra V; Lam SH; Carboni JM; Gottardis MM; Holzenberger M; Pollak M; Humphries RK; Weng AP
Exp Hematol; 2012 Sep; 40(9):715-723.e6. PubMed ID: 22613471
[TBL] [Abstract][Full Text] [Related]
19. Insulin/IGF-1 receptor signaling enhances biosynthetic activity and fat mobilization in the initial phase of starvation in adult male C. elegans.
Tan KT; Luo SC; Ho WZ; Lee YH
Cell Metab; 2011 Sep; 14(3):390-402. PubMed ID: 21907144
[TBL] [Abstract][Full Text] [Related]
20. The insulin/IGF signaling cascade modulates SUMOylation to regulate aging and proteostasis in
Moll L; Roitenberg N; Bejerano-Sagie M; Boocholez H; Carvalhal Marques F; Volovik Y; Elami T; Siddiqui AA; Grushko D; Biram A; Lampert B; Achache H; Ravid T; Tzur YB; Cohen E
Elife; 2018 Nov; 7():. PubMed ID: 30403374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
